26
1 The Patient Journey Evolution A Case Study Alex Zhu & Bill Salokar SKIM

The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

1

The Patient Journey Evolution

A Case Study

Alex Zhu & Bill Salokar

SKIM

Page 2: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Digital is transforming business and Healthcare is no exception

2

70%US consumers use a

digital channel to

manage health &

wellness

50%US HCPs use 3+

connected devices

professionally

1/5Top Pharma has a

chief digital officer

Page 3: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

But Pharma is lagging behind

3Source: Mckinsey

2227

31 32

3637

42

49

70-80

Global Average: 33

Distribution of Digital Quotient score by industry (global), points, out of 100

Public

Sector

Pharma Insurance Banking Media/

Entertainment

Telecom Retail Travel/

hospital

Digital

Leaders

Page 4: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Patients are empowered with

more info and choices than ever,

yet their expectations

haven’t been met

What is avg. time of

a HCP visit?

4

Page 5: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Patients expect more and better experience

5

Personalized

communication

• Format

• Tonality

• Interface

• Localized

One-stop experience

• Trusted one-stop info

source

• Simple and easy

interaction

Personalized services

• Alert

• Patient support

• Beyond the pill /

holistic therapy

Page 6: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

This calls for an evolution of patient journey & experience research

6

Patient centric Small data + Big dataActionable

Page 7: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Patient-Centric

7

Page 8: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

While it takes the patient perspective, traditional patient journey is largely a treatment journey

8

Initial

symptoms

Self research /

management HCP visit Diagnosis

Initiation

Therapy

New treatment

choiceEvaluation or

treatment and

symptoms

Changing symptoms

Page 9: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

What if we take a different starting point?

9

Denial Doubt Acceptance Control Doubt

Develop granular

patient stage profile

Focus on the stage-shifting

micro-moments

Page 10: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Case – an iterative approach starting with patient stage profiles

10

Phase 2 (converge)

Phase 1 (diverge)

Informational

Emotional

Clinical

Page 11: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Informational, emotional, and clinical gaps

11

Initial Symptoms Diagnosis Disease management

Unaware ConfusedOverwhelmed or

condescended

Skeptical and ill-

equipped

Left outSelf-conscious,

burdensomeUneasy, alone Isolated, disempowered

Unprepared Delayed Prolonged No systematic approach

Page 12: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Actionable

12

Page 13: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Qualitative journey work tends to be descriptive but lack focus

13

Page 14: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Making it actionable takes two level of prioritization

14

Sub-journeys Key Moments

Page 15: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Considerations to prioritize a sub-journey

15

1. Where is battle ground? (e.g. first to market vs. 4th line)

2. Highly important to a brand with immediate commercial impact (e.g. new patient on-

board journey)

3. Limited clarity & existing knowledge for a sub-journey (e.g. pain points in starting a new

biologic)

4. Targetable with current marketing programs (e.g. patient support)

5. Preferably with measurable metrics (e.g. establish a baseline on-board experience

measurement and track the results)

Page 16: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Action guide

16

What (Content) Where (Touchpoint)

Acquisition

Retention

Page 17: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Case – convergence phase focuses on key moments and key leverage points

17

Phase 1 (diverge)

Informational

Emotional

Clinical

Phase 2 (converge)

For each stage focus on

key moments

Identify key leverage

points for marketing

Page 18: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

18

Key influencers

Key leverage points

Initial Symptoms Diagnosis Management

Key Pt questions

Page 19: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Developing an ecosystem experience view centered around patients

19

Family members

Primary care providersAHP

Specialist 2Specialist 1

Page 20: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Key leverage points along the journey

20

Initial Symptoms Diagnosis Management

Leverage Point: Explain what

disease is and what to do if

symptoms present in order to obtain

an earlier diagnosis

Leverage Point: Establishing a comprehensive disease

symptom management / treatment plan presents an

opportunity for the HCP to restore trust with patients

Leverage Point: Explains detailed

information in patient-friendly

language, but does not overwhelm.

Leverage Point: social support

to prevent isolation, and

resources for handling social

situations and employment.

Leverage Point: Disease education is needed to target

HCPs and help them recognize disease more quickly in

these patients. Specialist 1 should be targeted in

particular.

Page 21: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Small Data + Big Data

21

Page 22: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Looking forward – three areas for integration

22

Quantitative data EMR Digital behavioral

data

Page 23: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Quantitative OTC Journey

23

Page 24: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

EMR

24

Page 25: The Patient Journey Evolution - SKIM · Considerations to prioritize a sub-journey 15 1. Where is battle ground? (e.g. first to market vs. 4th line) 2. Highly important to a brand

Digital Behavioral Data

25

Product Search Retailer Search

XXX Amazon

XX Walmart

YYY Target

ZZ Kmart

ABC Samsclub

CVS

Walgreens

Preceding Retailer Visit

Search

Engine25%

Coupon

Site13%

Other Retailer

Site9%

Email8%

Social

Media / News17%

No Preceding

Activity13%

Home Page43%

XX Related

Product Page21%

Web/App page11%

Brand Page9%

Ad/Deals/Special

Offers Page2%

First Page visited at a Retailer

Search Terms